SCHEMBL6173101

SCHEMBL6173101

CC(c1ccncc1NS(=O)(=O)NCc1ccccc1)C1NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
LIPE Q05469 4/20 0.35
FLT1 P17948 1/20 0.35
KDR P35968 1/20 0.35
CXCR3 P49682 3/20 0.34
CCR9 P51686 2/20 0.34
KDM5A P29375 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
ELANE P08246 1/20 0.33
KCNH2 Q12809 1/20 0.33
SCN5A Q14524 1/20 0.33
SCN9A Q15858 1/20 0.33
NAMPT P43490 2/20 0.33
TRPV1 Q8NER1 1/20 0.33
LARS1 Q9P2J5 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173841 0.90 LIPE (0.41) LMNALIPECXCR3CCR9KDM5A
SCHEMBL6177185 0.89 LMNA (0.41) LMNALIPECCR9
SCHEMBL6174151 0.89 NAMPT (0.35) LMNAELANENAMPTLARS1HTT
SCHEMBL6172043 0.88 IGF1R (0.37) LMNAKDM4CELANENAMPT
SCHEMBL6175499 0.87 LMNA (0.37) LMNALIPECXCR3CCR9
SCHEMBL6207151 0.87 CCR9 (0.44) LMNALIPECCR9
SCHEMBL6173186 0.82 LMNA (0.40) LMNALIPECXCR3CCR9KDM4C
SCHEMBL6175038 0.82 LMNA (0.38) LMNALIPEKDRKCNH2SCN5A
SCHEMBL6173298 0.81 LMNA (0.39) LMNALIPEFLT1KDRCXCR3
SCHEMBL6172197 0.81 LMNA (0.40) LMNALIPECXCR3CCR9KDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed